[{"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-001", "question": "A 14-month-old boy with genetically confirmed PMM2-CDG (p.Arg141His and p.Phe119Leu compound heterozygous variants) is scheduled for inguinal hernia repair. Preoperative coagulation studies show antithrombin III 45% (normal 80-120%), protein C 38% (normal 70-140%), and protein S 32% (normal 65-140%). All other labs are normal. What is the most appropriate perioperative management to minimize thrombotic risk?", "options": ["Proceed with surgery without prophylaxis; risk is theoretical", "Administer prophylactic enoxaparin 0.5 mg/kg subcutaneously 12 hours preoperatively and postoperatively", "Transfuse fresh frozen plasma to correct factor deficiencies before surgery", "Delay surgery indefinitely until coagulation factors normalize with nutritional support", "Administer antithrombin III concentrate 50 IU/kg immediately preoperatively"], "answer": "B", "answer_index": 1, "explanation": "PMM2-CDG causes combined antithrombin III, protein C, and protein S deficiency, creating significant thrombotic risk. For surgical prophylaxis, LMWH is recommended to address all deficient pathways. FFP provides insufficient correction and risks volume overload. ATIII concentrate alone doesn't address protein C/S deficiency. The thrombosis risk is not theoretical, with rates of 10-15% in moderate-severe cases.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a classic presentation of PMM2-CDG with associated coagulopathy (deficiency of glycosylated anticoagulants: Antithrombin III, Protein C, and Protein S). These patients are at high risk for venous thromboembolism, particularly during stress or surgery. The question asks for the most appropriate management to minimize thrombotic risk.\\n\\nOption B (LMWH prophylaxis) is the standard of care. Despite the low ATIII (45%), LMWH is widely recommended for surgical prophylaxis in CDG patients to mitigate the combined deficiency risks. While severe ATIII deficiency can induce heparin resistance, 45% is often sufficient for prophylactic effect, or LMWH is the first-line choice before considering factor replacement.\\n\\nOption A is incorrect as the risk is substantial, not theoretical. Option C (FFP) is suboptimal for routine prophylaxis due to volume overload risks and variable factor correction. Option D is incorrect because PMM2-CDG coagulopathy does not normalize with nutritional support alone. Option E (ATIII concentrate) addresses only one deficit and, without concurrent anticoagulation, is less effective than LMWH for broad prophylaxis.\\n\\nThe item is medically accurate and logically sound, presenting a clear best answer consistent with pediatric hematology and metabolic guidelines.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette describes a classic presentation of PMM2-CDG with associated coagulopathy (deficiency of glycosylated anticoagulants: Antithrombin III, Protein C, and Protein S). These patients are at high risk for venous thromboembolism, particularly during stress or surgery. The question asks for the most appropriate management to minimize thrombotic risk.\n\nOption B (LMWH prophylaxis) is the standard of care. Despite the low ATIII (45%), LMWH is widely recommended for surgical prophylaxis in CDG patients to mitigate the combined deficiency risks. While severe ATIII deficiency can induce heparin resistance, 45% is often sufficient for prophylactic effect, or LMWH is the first-line choice before considering factor replacement.\n\nOption A is incorrect as the risk is substantial, not theoretical. Option C (FFP) is suboptimal for routine prophylaxis due to volume overload risks and variable factor correction. Option D is incorrect because PMM2-CDG coagulopathy does not normalize with nutritional support alone. Option E (ATIII concentrate) addresses only one deficit and, without concurrent anticoagulation, is less effective than LMWH for broad prophylaxis.\n\nThe item is medically accurate and logically sound, presenting a clear best answer consistent with pediatric hematology and metabolic guidelines.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-002", "question": "A 3-year-old girl presents with opsoclonus-myoclonus syndrome and is found to have a right adrenal neuroblastoma with favorable histology, MYCN non-amplified. After tumor resection, neurologic symptoms persist despite high-dose steroids. Which immunotherapy targeting the specific B-cell mediated pathogenesis is most appropriate?", "options": ["Rituximab 375 mg/m² weekly for 4 weeks", "Cyclophosphamide 600 mg/m² monthly for 6 months", "Intravenous immunoglobulin 2 g/kg monthly", "Alemtuzumab 30 mg daily for 5 days", "Tocilizumab 8 mg/kg every 2 weeks"], "answer": "A", "answer_index": 0, "explanation": "Opsoclonus-myoclonus syndrome is mediated by anti-neuronal antibodies produced by B-cells. Rituximab depletes B-cells and is first-line for steroid-refractory cases. IVIG is adjunctive but not primary therapy. Cyclophosphamide is less specific and more toxic. Alemtuzumab is not standard and causes profound lymphodepletion. Tocilizumab targets IL-6, not the primary antibody-mediated pathogenesis.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic case of paraneoplastic opsoclonus-myoclonus syndrome (OMS) associated with neuroblastoma. The clinical scenario describes a patient who is refractory to tumor resection and corticosteroids. The question specifically asks for an immunotherapy that targets the 'specific B-cell mediated pathogenesis.' OMS is driven by autoantibodies, making B-cell depletion a logical therapeutic target. Rituximab (Option A) is a monoclonal antibody against CD20 that specifically depletes B-cells and is a standard second-line or concomitant therapy for moderate-to-severe OMS, particularly in steroid-refractory cases. While Cyclophosphamide (Option B) is used in refractory OMS, it is a non-specific alkylating agent with broader toxicity, not a targeted B-cell immunotherapy. IVIG (Option C) is often used first-line with steroids but acts via immunomodulation/neutralization rather than specific B-cell depletion. Alemtuzumab and Tocilizumab are not standard for this indication. The stem contains specific mechanistic clues ('targeting... B-cell') that make Rituximab the unique best answer among the choices.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic case of paraneoplastic opsoclonus-myoclonus syndrome (OMS) associated with neuroblastoma. The clinical scenario describes a patient who is refractory to tumor resection and corticosteroids. The question specifically asks for an immunotherapy that targets the 'specific B-cell mediated pathogenesis.' OMS is driven by autoantibodies, making B-cell depletion a logical therapeutic target. Rituximab (Option A) is a monoclonal antibody against CD20 that specifically depletes B-cells and is a standard second-line or concomitant therapy for moderate-to-severe OMS, particularly in steroid-refractory cases. While Cyclophosphamide (Option B) is used in refractory OMS, it is a non-specific alkylating agent with broader toxicity, not a targeted B-cell immunotherapy. IVIG (Option C) is often used first-line with steroids but acts via immunomodulation/neutralization rather than specific B-cell depletion. Alemtuzumab and Tocilizumab are not standard for this indication. The stem contains specific mechanistic clues ('targeting... B-cell') that make Rituximab the unique best answer among the choices.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-003", "question": "A 7-year-old girl with McCune-Albright syndrome (confirmed GNAS R201C mutation) presents with premature thelarche, vaginal bleeding, and a growth velocity of 12 cm/year. Bone age is 10 years. Which endocrine intervention specifically targets the underlying pathophysiology of precocious puberty in this condition?", "options": ["GnRH agonist (leuprolide) 7.5 mg IM monthly", "Aromatase inhibitor (letrozole) 2.5 mg daily", "Estrogen receptor antagonist (tamoxifen) 10 mg twice daily", "Progesterone-only contraceptive (medroxyprogesterone) 10 mg daily", "Ketoconazole 200 mg twice daily"], "answer": "B", "answer_index": 1, "explanation": "In McCune-Albright syndrome, precocious puberty results from autonomous ovarian hyperfunction, not central activation. GnRH agonists are ineffective because the process is gonadotropin-independent. Aromatase inhibitors block peripheral estrogen synthesis from autonomous follicular cysts. Tamoxifen is less effective and has more side effects. Progesterone doesn't address estrogen excess. Ketoconazole has significant toxicity.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic case of McCune-Albright syndrome (MAS) with peripheral precocious puberty. The question asks for the intervention targeting the underlying pathophysiology. The keyed answer, Letrozole (B), is an aromatase inhibitor that theoretically blocks autonomous estrogen synthesis. However, major clinical studies and expert guidelines (e.g., NIH/Endocrine Society) have found letrozole to be frequently ineffective in girls with MAS, often recommending Tamoxifen (C) as the preferred treatment. The author's rationale claims Tamoxifen is 'less effective,' which contradicts current high-level evidence. This creates a 'Multiple Defensible' issue: Option B fits a simplified mechanistic model (blocking synthesis), while Option C represents the actual clinical standard of care. A knowledgeable candidate cannot distinguish between the intended theoretical answer and the correct clinical answer without mind-reading the author's outdated or simplified viewpoint.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic case of McCune-Albright syndrome (MAS) with peripheral precocious puberty. The question asks for the intervention targeting the underlying pathophysiology. The keyed answer, Letrozole (B), is an aromatase inhibitor that theoretically blocks autonomous estrogen synthesis. However, major clinical studies and expert guidelines (e.g., NIH/Endocrine Society) have found letrozole to be frequently ineffective in girls with MAS, often recommending Tamoxifen (C) as the preferred treatment. The author's rationale claims Tamoxifen is 'less effective,' which contradicts current high-level evidence. This creates a 'Multiple Defensible' issue: Option B fits a simplified mechanistic model (blocking synthesis), while Option C represents the actual clinical standard of care. A knowledgeable candidate cannot distinguish between the intended theoretical answer and the correct clinical answer without mind-reading the author's outdated or simplified viewpoint.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-004", "question": "A 2-month-old infant with congenital lymphocytic choriomeningitis virus (LCMV) infection presents with chorioretinitis, hydrocephalus, and periventricular calcifications. Which neuroimaging finding best distinguishes LCMV from congenital cytomegalovirus infection?", "options": ["Periventricular calcifications", "Cortical malformations", "Cerebellar hypoplasia", "Temporal lobe cysts", "Lissencephaly"], "answer": "C", "answer_index": 2, "explanation": "While both LCMV and CMV can cause periventricular calcifications, LCMV characteristically causes severe cerebellar hypoplasia due to selective infection of the external granular layer cells. CMV more commonly causes cortical malformations, temporal lobe cysts, and lissencephaly. This distinction is critical for prognosis and genetic counseling, as LCMV has a higher risk of severe neurodevelopmental disability.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question describes a classic presentation of congenital Lymphocytic Choriomeningitis Virus (LCMV) (chorioretinitis, hydrocephalus, periventricular calcifications) and asks for a neuroimaging finding that distinguishes it from Cytomegalovirus (CMV). This is a valid 'compare and contrast' board-style item. Periventricular calcifications (Option A) are a hallmark of both infections and do not distinguish them. Cortical malformations (Option B), temporal lobe cysts (Option D), and lissencephaly (Option E) are classic, highly characteristic features of congenital CMV (associated with neuronal migration defects). By contrast, LCMV is distinctively associated with cerebellar hypoplasia (Option C) due to the virus's tropism for dividing neuroblasts in the cerebellum, often without the extensive cortical migration defects seen in CMV. Additionally, LCMV typically causes macrocephaly/hydrocephalus (as in the stem), whereas CMV typically causes microcephaly. By process of elimination and specific association, C is the only option that points towards LCMV rather than CMV. The item is logically sound and medically accurate regarding standard exam associations.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question describes a classic presentation of congenital Lymphocytic Choriomeningitis Virus (LCMV) (chorioretinitis, hydrocephalus, periventricular calcifications) and asks for a neuroimaging finding that distinguishes it from Cytomegalovirus (CMV). This is a valid 'compare and contrast' board-style item. Periventricular calcifications (Option A) are a hallmark of both infections and do not distinguish them. Cortical malformations (Option B), temporal lobe cysts (Option D), and lissencephaly (Option E) are classic, highly characteristic features of congenital CMV (associated with neuronal migration defects). By contrast, LCMV is distinctively associated with cerebellar hypoplasia (Option C) due to the virus's tropism for dividing neuroblasts in the cerebellum, often without the extensive cortical migration defects seen in CMV. Additionally, LCMV typically causes macrocephaly/hydrocephalus (as in the stem), whereas CMV typically causes microcephaly. By process of elimination and specific association, C is the only option that points towards LCMV rather than CMV. The item is logically sound and medically accurate regarding standard exam associations.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-005", "question": "A 5-year-old boy with DOCK8 deficiency (biallelic null variants) has recurrent Staphylococcus aureus skin abscesses, severe eczema, and recurrent pneumonias. Which prophylactic regimen specifically targets the predominant immunologic defect?", "options": ["Trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis", "Penicillin VK for streptococcal prophylaxis", "Itraconazole for fungal prophylaxis", "Azithromycin for atypical mycobacterial prophylaxis", "Valganciclovir for CMV prophylaxis"], "answer": "C", "answer_index": 2, "explanation": "DOCK8 deficiency is a combined immunodeficiency with impaired T-cell function leading to susceptibility to fungal infections, particularly Candida and dermatophytes. Itraconazole provides broad antifungal prophylaxis. TMP-SMX is for Pneumocystis but doesn't address the primary defect. Penicillin doesn't cover the main pathogens. Azithromycin is for atypical mycobacteria which are less common. Valganciclovir is for CMV which can occur but isn't the primary defect.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed; Option A is the superior best answer. DOCK8 deficiency is a Combined Immunodeficiency (CID) characterized by cytoskeletal defects affecting T-cell function. Unlike STAT3-Hyper-IgE syndrome, DOCK8 deficiency carries a high risk of Pneumocystis jirovecii pneumonia (PJP). Therefore, standard guidelines strongly recommend TMP-SMX (Option A) for PJP prophylaxis. TMP-SMX also provides coverage for Staphylococcus aureus, which is explicitly mentioned in the stem. While patients are also susceptible to fungal infections and Itraconazole (Option C) is often prescribed, PJP prophylaxis is the priority intervention for the T-cell defect component of this CID to prevent mortality. The author's rationale incorrectly minimizes the role of TMP-SMX, claiming it does not address the defect, whereas PJP susceptibility is a direct hallmark of the T-cell deficiency in DOCK8. Consequently, Option A is the most medically defensible 'best' answer. Minimal fix: Change the key to A, or modify the stem to specifically ask for prophylaxis against mucocutaneous fungal infections.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed; Option A is the superior best answer. DOCK8 deficiency is a Combined Immunodeficiency (CID) characterized by cytoskeletal defects affecting T-cell function. Unlike STAT3-Hyper-IgE syndrome, DOCK8 deficiency carries a high risk of Pneumocystis jirovecii pneumonia (PJP). Therefore, standard guidelines strongly recommend TMP-SMX (Option A) for PJP prophylaxis. TMP-SMX also provides coverage for Staphylococcus aureus, which is explicitly mentioned in the stem. While patients are also susceptible to fungal infections and Itraconazole (Option C) is often prescribed, PJP prophylaxis is the priority intervention for the T-cell defect component of this CID to prevent mortality. The author's rationale incorrectly minimizes the role of TMP-SMX, claiming it does not address the defect, whereas PJP susceptibility is a direct hallmark of the T-cell deficiency in DOCK8. Consequently, Option A is the most medically defensible 'best' answer. Minimal fix: Change the key to A, or modify the stem to specifically ask for prophylaxis against mucocutaneous fungal infections.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-006", "question": "A 28-year-old male with a dibucaine number of 20 (normal >70) and pseudocholinesterase activity of 0.2 U/mL (normal 0.5-1.2) requires emergency intubation for airway obstruction. After succinylcholine 1.5 mg/kg, apnea persists for 90 minutes. Which anesthetic agent should be avoided in future surgeries due to shared metabolic pathway?", "options": ["Rocuronium", "Ester local anesthetics (procaine, chloroprocaine)", "Vecuronium", "Cisatracurium", "Remifentanil"], "answer": "B", "answer_index": 1, "explanation": "A dibucaine number of 20 indicates homozygous atypical pseudocholinesterase. Succinylcholine and ester local anesthetics (procaine, chloroprocaine, tetracaine) are both metabolized by pseudocholinesterase. Aminosteroid relaxants (rocuronium, vecuronium) and benzylisoquinoliniums (cisatracurium) are not metabolized by this enzyme. Remifentanil is metabolized by non-specific esterases and is safe.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a patient with homozygous atypical pseudocholinesterase deficiency (Dibucaine number 20), confirmed by prolonged apnea after succinylcholine administration. The question asks to identify another agent metabolized by the same enzyme (pseudocholinesterase/butyrylcholinesterase). \\n\\nSuccinylcholine is metabolized by pseudocholinesterase. Among the options, only ester local anesthetics (Option B: procaine, chloroprocaine, tetracaine) are also metabolized by pseudocholinesterase. Consequently, their metabolism would be impaired in this patient, potentially leading to increased toxicity, making them the correct class to avoid or use with extreme caution. \\n\\nRocuronium and Vecuronium are aminosteroids (hepatic/renal elimination). Cisatracurium undergoes Hofmann elimination. Remifentanil is metabolized by non-specific plasma and tissue esterases, not pseudocholinesterase, and is safe in these patients. The item is medically accurate and logically sound with a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette describes a patient with homozygous atypical pseudocholinesterase deficiency (Dibucaine number 20), confirmed by prolonged apnea after succinylcholine administration. The question asks to identify another agent metabolized by the same enzyme (pseudocholinesterase/butyrylcholinesterase). \n\nSuccinylcholine is metabolized by pseudocholinesterase. Among the options, only ester local anesthetics (Option B: procaine, chloroprocaine, tetracaine) are also metabolized by pseudocholinesterase. Consequently, their metabolism would be impaired in this patient, potentially leading to increased toxicity, making them the correct class to avoid or use with extreme caution. \n\nRocuronium and Vecuronium are aminosteroids (hepatic/renal elimination). Cisatracurium undergoes Hofmann elimination. Remifentanil is metabolized by non-specific plasma and tissue esterases, not pseudocholinesterase, and is safe in these patients. The item is medically accurate and logically sound with a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-007", "question": "A 45-year-old male develops dyspnea 6 hours after interscalene brachial plexus block for shoulder surgery. Chest X-ray shows elevated right hemidiaphragm. Pulmonary function tests reveal: FVC 65% predicted, FEV1 70% predicted, FEV1/FVC 85%, TLC 70% predicted. Which PFT finding is most specific for phrenic nerve palsy versus other causes of dyspnea?", "options": ["Reduced FVC", "Preserved FEV1/FVC ratio", "Reduced TLC", "Paradoxical abdominal motion on examination", "Orthopnea"], "answer": "B", "answer_index": 1, "explanation": "Phrenic nerve palsy causes restrictive physiology with proportionate reduction in FVC and FEV1, preserving the FEV1/FVC ratio. Reduced TLC confirms restriction. While paradoxical abdominal motion is seen on examination, it is not a PFT finding. Orthopnea is nonspecific. The preserved ratio in context of reduced volumes is the key PFT pattern distinguishing restrictive from obstructive disease.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: N (No answer defensible). \\nVerdict: No defensible answer. \\nThe question asks for a PFT finding \\\"most specific\\\" for phrenic nerve palsy (PNP) versus other causes of dyspnea. While the vignette correctly identifies PNP (elevated hemidiaphragm post-block), the provided options fail to distinguish PNP from other relevant etiologies. The keyed answer, \\\"Preserved FEV1/FVC ratio\\\" (B), merely indicates a restrictive (or normal) pattern. This finding is present in all restrictive pathologies, including pneumothorax—a critical differential diagnosis for dyspnea following interscalene block. Since both PNP and pneumothorax present with reduced volumes and a preserved ratio, Option B is not specific. The diagnostic PFT hallmark of PNP is a significant (>20–30%) drop in FVC from upright to supine position, but this is not listed. Option D (paradoxical abdominal motion) is a specific physical sign but is explicitly excluded by the stem's constraint asking for a \\\"PFT finding.\\\" The item is flawed because it treats a generic pattern (restriction) as specific for a single etiology.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: N (No answer defensible). \nVerdict: No defensible answer. \nThe question asks for a PFT finding \"most specific\" for phrenic nerve palsy (PNP) versus other causes of dyspnea. While the vignette correctly identifies PNP (elevated hemidiaphragm post-block), the provided options fail to distinguish PNP from other relevant etiologies. The keyed answer, \"Preserved FEV1/FVC ratio\" (B), merely indicates a restrictive (or normal) pattern. This finding is present in all restrictive pathologies, including pneumothorax—a critical differential diagnosis for dyspnea following interscalene block. Since both PNP and pneumothorax present with reduced volumes and a preserved ratio, Option B is not specific. The diagnostic PFT hallmark of PNP is a significant (>20–30%) drop in FVC from upright to supine position, but this is not listed. Option D (paradoxical abdominal motion) is a specific physical sign but is explicitly excluded by the stem's constraint asking for a \"PFT finding.\" The item is flawed because it treats a generic pattern (restriction) as specific for a single etiology.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-008", "question": "A 22-year-old female with systemic lupus erythematosus presents with nihilistic delusions that her organs have 'turned to dust' and that she is already dead. CSF shows lymphocytic pleocytosis and elevated protein. Which specific autoantibody is most strongly associated with this neuropsychiatric manifestation?", "options": ["Anti-dsDNA", "Anti-NR2A (NMDA receptor)", "Anti-Ro/SSA", "Anti-phospholipid", "Anti-Sm"], "answer": "B", "answer_index": 1, "explanation": "Anti-NR2A antibodies targeting NMDA receptors correlate strongly with diffuse neuropsychiatric SLE manifestations including psychosis, delusional states, and cognitive dysfunction. Anti-dsDNA is a general SLE marker without specific neuropsychiatric correlation. Anti-Ro is associated with neonatal lupus. Antiphospholipid antibodies cause thrombotic events. Anti-Sm is specific for SLE but not associated with particular neuropsychiatric features.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with Systemic Lupus Erythematosus (SLE) presenting with severe neuropsychiatric symptoms (psychosis/delusions) and inflammatory CSF findings, consistent with diffuse Neuropsychiatric SLE (NPSLE). The question asks for the autoantibody most strongly associated with this manifestation. Among the choices, Anti-NR2A (a subset of anti-dsDNA antibodies that cross-react with the NMDA receptor NR2A/B subunits) is the correct best answer. These antibodies are well-documented in the literature to be associated with diffuse NPSLE, including psychosis, cognitive dysfunction, and mood disorders, due to potential excitotoxicity. While Anti-Ribosomal P is another classic marker for SLE psychosis, it is not offered as an option. Anti-phospholipid antibodies (Option D) are typically associated with focal neurological deficits (stroke/TIA) due to thrombosis rather than the diffuse inflammatory psychosis described. Anti-dsDNA (Option A) is a general marker for SLE activity and nephritis but lacks the specific strong correlation with neuropsychiatric features compared to Anti-NR2A. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with Systemic Lupus Erythematosus (SLE) presenting with severe neuropsychiatric symptoms (psychosis/delusions) and inflammatory CSF findings, consistent with diffuse Neuropsychiatric SLE (NPSLE). The question asks for the autoantibody most strongly associated with this manifestation. Among the choices, Anti-NR2A (a subset of anti-dsDNA antibodies that cross-react with the NMDA receptor NR2A/B subunits) is the correct best answer. These antibodies are well-documented in the literature to be associated with diffuse NPSLE, including psychosis, cognitive dysfunction, and mood disorders, due to potential excitotoxicity. While Anti-Ribosomal P is another classic marker for SLE psychosis, it is not offered as an option. Anti-phospholipid antibodies (Option D) are typically associated with focal neurological deficits (stroke/TIA) due to thrombosis rather than the diffuse inflammatory psychosis described. Anti-dsDNA (Option A) is a general marker for SLE activity and nephritis but lacks the specific strong correlation with neuropsychiatric features compared to Anti-NR2A. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-009", "question": "A 35-year-old male with treatment-resistant schizophrenia is started on clozapine. He is HLA-DQB1*05:02 positive and HLA-B*38:02 negative. Which monitoring protocol is specifically indicated based on his genetic profile?", "options": ["Weekly CBC for 52 weeks, then monthly", "Weekly CBC for 26 weeks, then every 2 weeks to 52 weeks, then monthly", "Baseline CBC, then monthly only", "Weekly CBC for 6 months, then discontinue if stable", "No CBC monitoring required"], "answer": "B", "answer_index": 1, "explanation": "HLA-DQB1*05:02 is associated with increased clozapine-induced agranulocytosis risk, requiring extended intensive monitoring for 26 weeks before tapering frequency. HLA-B*38:02 is protective. Standard protocol is weekly for 6 months, but high-risk genotypes require longer intensive monitoring as per CPIC guidelines. Discontinuing monitoring or monthly-only monitoring is unsafe in this genetic context.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is logically incoherent and medically inaccurate. The keyed answer (B) describes the standard FDA monitoring protocol for clozapine (weekly for 6 months/26 weeks, then biweekly). However, the rationale states that the 'standard protocol is weekly for 6 months' but that high-risk genotypes 'require longer intensive monitoring.' This creates a direct contradiction: the rationale argues for a protocol longer than 6 months (which would imply Option A), yet selects Option B (which is exactly 6 months of weekly monitoring). Furthermore, current major guidelines (e.g., CPIC, FDA) do not recommend a specific, codified alteration to the monitoring schedule based solely on HLA genotype; the standard of care is to follow the REMS protocol for all patients. The stem's phrase 'specifically indicated based on his genetic profile' implies a deviation from standard care, but the key represents standard care. This makes the item a 'trick' question with a contradictory explanation.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is logically incoherent and medically inaccurate. The keyed answer (B) describes the standard FDA monitoring protocol for clozapine (weekly for 6 months/26 weeks, then biweekly). However, the rationale states that the 'standard protocol is weekly for 6 months' but that high-risk genotypes 'require longer intensive monitoring.' This creates a direct contradiction: the rationale argues for a protocol longer than 6 months (which would imply Option A), yet selects Option B (which is exactly 6 months of weekly monitoring). Furthermore, current major guidelines (e.g., CPIC, FDA) do not recommend a specific, codified alteration to the monitoring schedule based solely on HLA genotype; the standard of care is to follow the REMS protocol for all patients. The stem's phrase 'specifically indicated based on his genetic profile' implies a deviation from standard care, but the key represents standard care. This makes the item a 'trick' question with a contradictory explanation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-010", "question": "A 7-year-old boy presents with 18-month history of progressive social withdrawal, flattened affect, disorganized speech, and tactile hallucinations of 'bugs crawling under my skin.' He has no prior developmental delays. Which specific prodromal feature best predicts conversion to definitive schizophrenia in children?", "options": ["Social isolation", "Flattened affect", "Disorganized speech", "Tactile hallucinations", "Decline in academic performance"], "answer": "D", "answer_index": 3, "explanation": "While social isolation and affective flattening are common prodromal symptoms, tactile hallucinations are uncommon in childhood and strongly predict conversion to schizophrenia spectrum disorders. Auditory hallucinations are more frequent but less specific. The presence of multimodal hallucinations, particularly somatic/tactile, increases risk substantially and warrants aggressive early intervention.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item contains a fundamental logical contradiction and medical inaccuracy. The vignette describes a patient with an 18-month history of disorganized speech, negative symptoms (withdrawal, flattened affect), and hallucinations. Under DSM-5, this patient already meets the diagnostic criteria for Schizophrenia (2+ Criterion A symptoms, duration >6 months). Therefore, asking which feature predicts 'conversion to definitive schizophrenia' is logically incoherent, as the patient has already converted. Furthermore, the keyed answer (Tactile hallucinations) is medically questionable. In pediatric psychiatry, tactile hallucinations are rare in primary psychotic disorders and strongly suggest organic etiologies (e.g., delirium, substance use, neurological conditions). Standard medical consensus identifies 'attenuated positive symptoms' (particularly unusual thought content and suspiciousness) and functional decline as the strongest predictors of conversion in clinical high-risk populations. Promoting tactile hallucinations as a specific predictor for schizophrenia ignores the organic differential and contradicts standard teaching.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item contains a fundamental logical contradiction and medical inaccuracy. The vignette describes a patient with an 18-month history of disorganized speech, negative symptoms (withdrawal, flattened affect), and hallucinations. Under DSM-5, this patient already meets the diagnostic criteria for Schizophrenia (2+ Criterion A symptoms, duration >6 months). Therefore, asking which feature predicts 'conversion to definitive schizophrenia' is logically incoherent, as the patient has already converted. Furthermore, the keyed answer (Tactile hallucinations) is medically questionable. In pediatric psychiatry, tactile hallucinations are rare in primary psychotic disorders and strongly suggest organic etiologies (e.g., delirium, substance use, neurological conditions). Standard medical consensus identifies 'attenuated positive symptoms' (particularly unusual thought content and suspiciousness) and functional decline as the strongest predictors of conversion in clinical high-risk populations. Promoting tactile hallucinations as a specific predictor for schizophrenia ignores the organic differential and contradicts standard teaching.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-011", "question": "A 14-year-old female presents with fever, weight loss, claudication in left arm, and blood pressure discrepancy of 30 mmHg between arms. MRA shows stenosis of left subclavian artery and abdominal aorta. According to childhood Takayasu arteritis criteria, which additional finding is required for definitive diagnosis?", "options": ["Elevated ESR >40 mm/hr", "Positive ANA titer >1:320", "Stenosis of >3 vascular territories", "Presence of pulmonary artery involvement", "Age at diagnosis <16 years"], "answer": "C", "answer_index": 2, "explanation": "Childhood Takayasu arteritis per EULAR/PRINTO criteria requires angiographic abnormalities plus either typical symptoms or elevated inflammatory markers, AND involvement of >3 vascular territories. Adult criteria are less stringent. Pulmonary artery involvement is supportive but not required. Age is part of classification but not a diagnostic criterion. ANA positivity is not required.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (No answer defensible). The item is medically inaccurate. The patient described in the vignette already meets the EULAR/PRINTO/PRES classification criteria for childhood Takayasu arteritis (mandatory angiographic abnormality of aorta/branches plus claudication and blood pressure discrepancy). Therefore, no \\\"additional\\\" finding is required for classification. Furthermore, the Key (C) claims a requirement for \\\"stenosis of >3 vascular territories,\\\" which is not a component of the standard EULAR/PRINTO/PRES criteria (nor the adult ACR criteria). The author likely confused the ACR requirement to meet \\\"3 out of 6 criteria\\\" with \\\"3 vascular territories.\\\" Since the patient is already classifiable based on the stem and the keyed requirement is fictitious, the question is unanswerable. A correct question would ask for the mandatory criterion (angiographic abnormality) or a valid supportive feature, but the current options and key are flawed.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (No answer defensible). The item is medically inaccurate. The patient described in the vignette already meets the EULAR/PRINTO/PRES classification criteria for childhood Takayasu arteritis (mandatory angiographic abnormality of aorta/branches plus claudication and blood pressure discrepancy). Therefore, no \"additional\" finding is required for classification. Furthermore, the Key (C) claims a requirement for \"stenosis of >3 vascular territories,\" which is not a component of the standard EULAR/PRINTO/PRES criteria (nor the adult ACR criteria). The author likely confused the ACR requirement to meet \"3 out of 6 criteria\" with \"3 vascular territories.\" Since the patient is already classifiable based on the stem and the keyed requirement is fictitious, the question is unanswerable. A correct question would ask for the mandatory criterion (angiographic abnormality) or a valid supportive feature, but the current options and key are flawed.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-012", "question": "A 3-week-old neonate presents with intractable seizures unresponsive to phenobarbital and levetiracetam. EEG shows burst-suppression pattern. CSF neurotransmitter analysis shows elevated 3-methoxy-4-hydroxyphenylglycol (MHPG) and reduced homovanillic acid (HVA). Which specific enzyme deficiency is suggested by this pattern?", "options": ["Pyridoxine 5'-phosphate oxidase", "GABA transaminase", "Aromatic L-amino acid decarboxylase", "Pyridoxal kinase", "Succinic semialdehyde dehydrogenase"], "answer": "A", "answer_index": 0, "explanation": "Pyridoxine 5'-phosphate oxidase (PNPO) deficiency impairs conversion of pyridoxine 5'-phosphate to pyridoxal 5'-phosphate, the active cofactor for GABA synthesis. CSF shows elevated MHPG/HVA ratio >2.5, which is pathognomonic. AADC deficiency shows reduced HVA and 5-HIAA. Pyridoxal kinase deficiency has different metabolite ratios. SSADH deficiency shows elevated GABA.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a neonate with intractable seizures and a burst-suppression pattern, suggestive of a metabolic epileptic encephalopathy. The CSF findings of reduced homovanillic acid (HVA) indicate a defect in dopamine synthesis or metabolism. The intended answer is Pyridoxine 5'-phosphate oxidase (PNPO) deficiency (Option A), which leads to reduced pyridoxal 5'-phosphate (PLP), a cofactor for Aromatic L-amino acid decarboxylase (AADC). This results in secondary AADC deficiency, causing low HVA and 5-HIAA. However, the stem states that MHPG is \\\"elevated.\\\" This is medically inaccurate. In PNPO deficiency, MHPG is typically normal or slightly reduced (spared relative to HVA), resulting in a pathognomonic elevated MHPG/HVA *ratio*. Mechanistically, a block in AADC prevents the synthesis of dopamine and its downstream product norepinephrine; therefore, MHPG (a norepinephrine metabolite) cannot be absolutely elevated when HVA is reduced due to synthesis failure. This factual error makes the stem describe a physiologically impossible profile for the keyed diagnosis. While Option A is the intended best answer (distinguished from primary AADC deficiency where MHPG is markedly low), the stem's claim of \\\"elevated MHPG\\\" renders the question strictly invalid as no option fits this description.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a neonate with intractable seizures and a burst-suppression pattern, suggestive of a metabolic epileptic encephalopathy. The CSF findings of reduced homovanillic acid (HVA) indicate a defect in dopamine synthesis or metabolism. The intended answer is Pyridoxine 5'-phosphate oxidase (PNPO) deficiency (Option A), which leads to reduced pyridoxal 5'-phosphate (PLP), a cofactor for Aromatic L-amino acid decarboxylase (AADC). This results in secondary AADC deficiency, causing low HVA and 5-HIAA. However, the stem states that MHPG is \"elevated.\" This is medically inaccurate. In PNPO deficiency, MHPG is typically normal or slightly reduced (spared relative to HVA), resulting in a pathognomonic elevated MHPG/HVA *ratio*. Mechanistically, a block in AADC prevents the synthesis of dopamine and its downstream product norepinephrine; therefore, MHPG (a norepinephrine metabolite) cannot be absolutely elevated when HVA is reduced due to synthesis failure. This factual error makes the stem describe a physiologically impossible profile for the keyed diagnosis. While Option A is the intended best answer (distinguished from primary AADC deficiency where MHPG is markedly low), the stem's claim of \"elevated MHPG\" renders the question strictly invalid as no option fits this description.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-013", "question": "A 2-month-old infant presents with heart failure, mitral regurgitation, and echocardiographic finding of retrograde flow in a dilated left coronary artery during diastole. Which additional echocardiographic finding is pathognomonic for anomalous left coronary artery from pulmonary artery (ALCAPA)?", "options": ["Left ventricular dilation", "Papillary muscle dysfunction", "Septal wall motion abnormalities", "Coronary artery collaterals with 'seagull' sign", "Right coronary artery dilation"], "answer": "D", "answer_index": 3, "explanation": "In ALCAPA, extensive intercoronary collaterals develop with characteristic bidirectional flow seen on color Doppler as a 'seagull' sign. While LV dilation, papillary muscle dysfunction, and RCA dilation are seen, they are not pathognomonic. The seagull sign represents collaterals from RCA to LCA with flow reversal into PA, which is diagnostic of ALCAPA.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of ALCAPA (Anomalous Left Coronary Artery from the Pulmonary Artery) with heart failure and retrograde LCA flow. The question asks for an additional pathognomonic finding. Options A (LV dilation), B (papillary muscle dysfunction), and C (septal wall motion abnormalities) are non-specific consequences of myocardial ischemia and volume overload, seen in various cardiomyopathies. Option E (RCA dilation) is a strong supportive finding (compensatory response) but can be seen in other coronary anomalies (e.g., fistulas). Option D refers to the specific visualization of intercoronary collaterals and the 'seagull sign' (a specific color Doppler appearance of the flow at the LCA bifurcation/entry into the PA). While the stem already mentions retrograde flow (which is diagnostic), Option D is the only choice that describes the unique vascular architecture/flow pattern specific to ALCAPA, distinguishing it from generic heart failure causes. Therefore, D is the defensible best answer.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of ALCAPA (Anomalous Left Coronary Artery from the Pulmonary Artery) with heart failure and retrograde LCA flow. The question asks for an additional pathognomonic finding. Options A (LV dilation), B (papillary muscle dysfunction), and C (septal wall motion abnormalities) are non-specific consequences of myocardial ischemia and volume overload, seen in various cardiomyopathies. Option E (RCA dilation) is a strong supportive finding (compensatory response) but can be seen in other coronary anomalies (e.g., fistulas). Option D refers to the specific visualization of intercoronary collaterals and the 'seagull sign' (a specific color Doppler appearance of the flow at the LCA bifurcation/entry into the PA). While the stem already mentions retrograde flow (which is diagnostic), Option D is the only choice that describes the unique vascular architecture/flow pattern specific to ALCAPA, distinguishing it from generic heart failure causes. Therefore, D is the defensible best answer.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-014", "question": "A 3-week-old neonate presents with watery diarrhea, dehydration, and metabolic alkalosis. Stool chloride is 120 mEq/L (normal <20). Genetic testing confirms CLCN5 mutation. Which electrolyte pattern is most specific for congenital chloride diarrhea versus other causes of neonatal secretory diarrhea?", "options": ["Hypochloremia, hyponatremia, metabolic alkalosis", "Hypochloremia, hyponatremia, metabolic acidosis", "Hyperchloremia, hypernatremia, metabolic alkalosis", "Hyperchloremia, hyponatremia, metabolic alkalosis", "Normal chloride, hyponatremia, metabolic acidosis"], "answer": "A", "answer_index": 0, "explanation": "CLCN5 mutation impairs ileal chloride-bicarbonate exchange, causing massive chloride loss, hypochloremia, and secondary metabolic alkalosis. Hyponatremia occurs from volume contraction. This contrasts with other secretory diarrheas which typically cause metabolic acidosis. Stool chloride >90 mEq/L is diagnostic and distinguishes it from other causes.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Correct best answer. The clinical vignette describes classic Congenital Chloride Diarrhea (CCD): neonatal watery diarrhea, dehydration, high stool chloride (>90 mEq/L), and metabolic alkalosis. The question asks for the electrolyte pattern specific to CCD. CCD is caused by a defect in the ileal Cl⁻/HCO₃⁻ exchanger, leading to massive fecal chloride loss (hypochloremia) and bicarbonate retention (metabolic alkalosis), often with secondary hyponatremia due to volume depletion. Option A correctly describes this pattern, which distinguishes CCD from most other secretory diarrheas that cause metabolic acidosis. However, the item contains a significant medical error: it attributes the condition to a \\\"CLCN5 mutation.\\\" *CLCN5* mutations cause Dent disease (X-linked nephrolithiasis/proteinuria), not CCD. The correct gene for CCD is *SLC26A3* (DRA). Despite this factual inaccuracy, the item is logically solvable because the clinical presentation and the explicit naming of the disease in the interrogative point uniquely to Option A. Minimal fix: Change \\\"CLCN5\\\" to \\\"SLC26A3\\\".\",\"medical_accuracy_score\":\"2\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Correct best answer. The clinical vignette describes classic Congenital Chloride Diarrhea (CCD): neonatal watery diarrhea, dehydration, high stool chloride (>90 mEq/L), and metabolic alkalosis. The question asks for the electrolyte pattern specific to CCD. CCD is caused by a defect in the ileal Cl⁻/HCO₃⁻ exchanger, leading to massive fecal chloride loss (hypochloremia) and bicarbonate retention (metabolic alkalosis), often with secondary hyponatremia due to volume depletion. Option A correctly describes this pattern, which distinguishes CCD from most other secretory diarrheas that cause metabolic acidosis. However, the item contains a significant medical error: it attributes the condition to a \"CLCN5 mutation.\" *CLCN5* mutations cause Dent disease (X-linked nephrolithiasis/proteinuria), not CCD. The correct gene for CCD is *SLC26A3* (DRA). Despite this factual inaccuracy, the item is logically solvable because the clinical presentation and the explicit naming of the disease in the interrogative point uniquely to Option A. Minimal fix: Change \"CLCN5\" to \"SLC26A3\".", "medical_accuracy_score": 2, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-015", "question": "A 6-year-old boy presents with low molecular weight proteinuria, hypercalciuria, and nephrocalcinosis. Genetic testing confirms OCRL1 mutation (Dent disease type 2). Which specific tubular transport defect is characteristic of Dent disease?", "options": ["Proximal tubular phosphate reabsorption defect", "Proximal tubular glucose reabsorption defect", "Loop of Henle chloride reabsorption defect", "Distal tubular proton secretion defect", "Collecting duct water reabsorption defect"], "answer": "A", "answer_index": 0, "explanation": "Dent disease is caused by OCRL1 or CLCN5 mutations affecting proximal tubular endocytosis via the megalin/cubilin pathway, causing low molecular weight proteinuria, hypercalciuria, and phosphate wasting. It does not primarily affect glucose, chloride, proton, or water transport. The proximal tubular phosphate defect distinguishes it from other tubular disorders.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item describes a classic presentation of Dent disease type 2 (LMW proteinuria, hypercalciuria, nephrocalcinosis, OCRL1 mutation). The question asks for a characteristic tubular transport defect. Dent disease is a proximal tubulopathy resulting from endocytic dysfunction. While the primary hallmarks are LMW proteinuria and hypercalciuria, it is frequently associated with renal phosphate wasting (hypophosphatemia), which is often cited as a diagnostic criterion or major feature (Option A). While Dent disease is sometimes called a 'partial Fanconi syndrome,' glycosuria (Option B) is less consistent and less prominent than phosphate wasting in the Dent phenotype compared to full Fanconi syndrome (or Lowe syndrome, which also involves OCRL1 but presents with full Fanconi). Options C, D, and E describe defects associated with Bartter syndrome, Distal RTA, and Nephrogenic Diabetes Insipidus, respectively, and are incorrect for Dent disease. The item is medically accurate, and the distractors are well-differentiated.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item describes a classic presentation of Dent disease type 2 (LMW proteinuria, hypercalciuria, nephrocalcinosis, OCRL1 mutation). The question asks for a characteristic tubular transport defect. Dent disease is a proximal tubulopathy resulting from endocytic dysfunction. While the primary hallmarks are LMW proteinuria and hypercalciuria, it is frequently associated with renal phosphate wasting (hypophosphatemia), which is often cited as a diagnostic criterion or major feature (Option A). While Dent disease is sometimes called a 'partial Fanconi syndrome,' glycosuria (Option B) is less consistent and less prominent than phosphate wasting in the Dent phenotype compared to full Fanconi syndrome (or Lowe syndrome, which also involves OCRL1 but presents with full Fanconi). Options C, D, and E describe defects associated with Bartter syndrome, Distal RTA, and Nephrogenic Diabetes Insipidus, respectively, and are incorrect for Dent disease. The item is medically accurate, and the distractors are well-differentiated.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-016", "question": "A 6-year-old child with CYP2D6 ultra-rapid metabolizer genotype (gene duplication) undergoes tonsillectomy. Postoperatively, he receives codeine 1 mg/kg q6h for pain. Which specific monitoring parameter is most critical in the first 24 hours to detect opioid toxicity?", "options": ["Respiratory rate every 4 hours", "Continuous pulse oximetry for 24 hours", "Pain score assessment every 2 hours", "Sedation score every hour for 8 hours", "Capnography for 12 hours"], "answer": "B", "answer_index": 1, "explanation": "CYP2D6 ultra-rapid metabolizers convert codeine to morphine at rates 2-10x normal, causing unpredictable and life-threatening respiratory depression. The FDA specifically contraindicates codeine in these children post-tonsillectomy. Continuous pulse oximetry is most sensitive for detecting early respiratory depression. Sedation scores are less reliable. Capnography is not standard of care.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a clinical scenario involving a strict contraindication: codeine should never be administered to a child post-tonsillectomy, particularly one with a known CYP2D6 ultra-rapid metabolizer genotype, due to the risk of fatal respiratory depression (FDA Black Box Warning). While the question asks for monitoring 'given' this error, the keyed answer (B) relies on the medically inaccurate premise that pulse oximetry is the 'most sensitive' method for detecting respiratory depression. Physiologically, pulse oximetry detects hypoxemia, which is a late lag-indicator of hypoventilation. Capnography (Option E) is the gold standard for detecting early hypoventilation, and sedation assessment (Option D) is widely cited as the earliest clinical sign of opioid toxicity (preceding respiratory rate changes). While the author dismisses capnography as 'not standard of care,' it is the superior modality for this specific high-risk 'poisoning' scenario. Consequently, Options D and E are medically superior to B for 'detection,' while B represents a 'standard' but less sensitive safety net. This conflict between physiologic accuracy and 'standard ward practice' makes multiple answers defensible.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a clinical scenario involving a strict contraindication: codeine should never be administered to a child post-tonsillectomy, particularly one with a known CYP2D6 ultra-rapid metabolizer genotype, due to the risk of fatal respiratory depression (FDA Black Box Warning). While the question asks for monitoring 'given' this error, the keyed answer (B) relies on the medically inaccurate premise that pulse oximetry is the 'most sensitive' method for detecting respiratory depression. Physiologically, pulse oximetry detects hypoxemia, which is a late lag-indicator of hypoventilation. Capnography (Option E) is the gold standard for detecting early hypoventilation, and sedation assessment (Option D) is widely cited as the earliest clinical sign of opioid toxicity (preceding respiratory rate changes). While the author dismisses capnography as 'not standard of care,' it is the superior modality for this specific high-risk 'poisoning' scenario. Consequently, Options D and E are medically superior to B for 'detection,' while B represents a 'standard' but less sensitive safety net. This conflict between physiologic accuracy and 'standard ward practice' makes multiple answers defensible.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-017", "question": "A 30-year-old female with acute intermittent porphyria requires general anesthesia for laparoscopic cholecystectomy. Which anesthetic agent is specifically contraindicated due to its porphyrinogenic effect?", "options": ["Propofol", "Sevoflurane", "Etomidate", "Thiopental", "Desflurane"], "answer": "D", "answer_index": 3, "explanation": "Barbiturates like thiopental are absolutely contraindicated in acute porphyrias as they strongly induce hepatic ALA synthase, triggering life-threatening attacks. Propofol, etomidate, and volatile agents (sevoflurane, desflurane) are considered safe. The question tests knowledge of specific porphyrinogenic drugs that must be avoided in this population.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Correct, but not unique.\\n\\nThe question asks to identify an anesthetic agent specifically contraindicated in acute intermittent porphyria (AIP). The keyed answer, Thiopental (D), is a barbiturate and is classically contraindicated due to potent induction of ALA synthase. However, Option C (Etomidate) is also widely classified as porphyrinogenic and unsafe/contraindicated in AIP by major pharmacological databases (e.g., NAPOS, UK Porphyria Medicines Information Service) and standard anesthesia textbooks (Miller, Barash). The author's rationale incorrectly states that Etomidate is considered safe; this contradicts current consensus which advises avoiding both barbiturates and etomidate. Consequently, both C and D are defensible correct answers. To establish a single best answer, Etomidate must be replaced with a clearly safe alternative, such as Ketamine or Midazolam.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Correct, but not unique.\n\nThe question asks to identify an anesthetic agent specifically contraindicated in acute intermittent porphyria (AIP). The keyed answer, Thiopental (D), is a barbiturate and is classically contraindicated due to potent induction of ALA synthase. However, Option C (Etomidate) is also widely classified as porphyrinogenic and unsafe/contraindicated in AIP by major pharmacological databases (e.g., NAPOS, UK Porphyria Medicines Information Service) and standard anesthesia textbooks (Miller, Barash). The author's rationale incorrectly states that Etomidate is considered safe; this contradicts current consensus which advises avoiding both barbiturates and etomidate. Consequently, both C and D are defensible correct answers. To establish a single best answer, Etomidate must be replaced with a clearly safe alternative, such as Ketamine or Midazolam.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-018", "question": "A 28-year-old female with SLE presents with psychosis, catatonia, and seizures. CSF shows anti-NR2A antibodies. Which specific immunosuppressive regimen is most effective for antibody-mediated neuropsychiatric SLE?", "options": ["High-dose steroids alone", "Cyclophosphamide 500 mg/m² monthly", "Rituximab 375 mg/m² weekly × 4 plus high-dose steroids", "Mycophenolate mofetil 2 g daily", "Intravenous immunoglobulin 2 g/kg monthly"], "answer": "C", "answer_index": 2, "explanation": "Anti-NR2A antibody-mediated neuropsychiatric SLE requires B-cell depletion with rituximab plus high-dose steroids. Steroids alone are insufficient. Cyclophosphamide is less effective for antibody-mediated disease. Mycophenolate is maintenance therapy. IVIG is adjunctive. The combination of rituximab and steroids provides rapid clearance of pathogenic antibodies.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a patient with severe, life-threatening neuropsychiatric SLE (NPSLE) manifesting as psychosis, catatonia, and seizures, with positive anti-NR2A antibodies. The question asks for the 'most effective' specific immunosuppressive regimen. According to major international guidelines (e.g., EULAR/ACR), the standard of care for severe inflammatory NPSLE is induction with high-dose glucocorticoids combined with intravenous cyclophosphamide (Option B). Rituximab (Option C) is widely recognized as an effective therapy and is mechanistically sound for antibody-mediated disease (depleting B-cells); however, it is typically reserved for refractory cases or specific phenotypes in specialized centers, rather than being the universal first-line standard over cyclophosphamide. The provided rationale claims cyclophosphamide is 'less effective for antibody-mediated disease,' which is medically inaccurate (CYC is highly effective for antibody-mediated lupus nephritis and NPSLE). Consequently, Option B is the best answer based on standard guidelines, while Option C is the best answer based on the author's specific mechanistic logic. This creates a situation where two answers are defensible depending on the frame of reference (guidelines vs. mechanism).\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a patient with severe, life-threatening neuropsychiatric SLE (NPSLE) manifesting as psychosis, catatonia, and seizures, with positive anti-NR2A antibodies. The question asks for the 'most effective' specific immunosuppressive regimen. According to major international guidelines (e.g., EULAR/ACR), the standard of care for severe inflammatory NPSLE is induction with high-dose glucocorticoids combined with intravenous cyclophosphamide (Option B). Rituximab (Option C) is widely recognized as an effective therapy and is mechanistically sound for antibody-mediated disease (depleting B-cells); however, it is typically reserved for refractory cases or specific phenotypes in specialized centers, rather than being the universal first-line standard over cyclophosphamide. The provided rationale claims cyclophosphamide is 'less effective for antibody-mediated disease,' which is medically inaccurate (CYC is highly effective for antibody-mediated lupus nephritis and NPSLE). Consequently, Option B is the best answer based on standard guidelines, while Option C is the best answer based on the author's specific mechanistic logic. This creates a situation where two answers are defensible depending on the frame of reference (guidelines vs. mechanism).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-019", "question": "A 78-year-old female with major depressive disorder is started on sertraline 50 mg daily. She has SIADH risk factors: age >65, female, concomitant thiazide diuretic. Which electrolyte monitoring protocol is recommended?", "options": ["Baseline sodium only", "Baseline and 1-week sodium", "Baseline, 1-week, and 2-week sodium", "Baseline, 1-week, 2-week, and 4-week sodium", "Weekly sodium for 8 weeks"], "answer": "D", "answer_index": 3, "explanation": "SIADH from SSRIs typically occurs within 2-4 weeks. High-risk patients (elderly, female, diuretic use) require sodium monitoring at baseline, 1, 2, and 4 weeks. More frequent monitoring is unnecessary if stable. Baseline alone or single follow-up is insufficient. Weekly monitoring for 8 weeks is excessive and not guideline-recommended.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity: Valid (V). Verdict: Keyed answer is the best defensible option. The vignette describes a patient with multiple high-risk factors for SSRI-induced SIADH (age >65, female, concomitant thiazide). Hyponatremia from SSRIs typically develops within the first 2–4 weeks of treatment. Standard expert consensus (e.g., Maudsley Prescribing Guidelines, clinical reviews) recommends monitoring sodium at baseline and then at intervals covering the first month (commonly 2 and 4 weeks, or 1, 2, and 4 weeks for high-risk cases). Options A and B are insufficient as they miss the peak incidence window. Option C stops at 2 weeks, potentially missing delayed onset. Option E is clinically excessive. Option D (Baseline, 1, 2, and 4 weeks) provides the most appropriate safety monitoring for this specific high-risk profile among the choices provided.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: Valid (V). Verdict: Keyed answer is the best defensible option. The vignette describes a patient with multiple high-risk factors for SSRI-induced SIADH (age >65, female, concomitant thiazide). Hyponatremia from SSRIs typically develops within the first 2–4 weeks of treatment. Standard expert consensus (e.g., Maudsley Prescribing Guidelines, clinical reviews) recommends monitoring sodium at baseline and then at intervals covering the first month (commonly 2 and 4 weeks, or 1, 2, and 4 weeks for high-risk cases). Options A and B are insufficient as they miss the peak incidence window. Option C stops at 2 weeks, potentially missing delayed onset. Option E is clinically excessive. Option D (Baseline, 1, 2, and 4 weeks) provides the most appropriate safety monitoring for this specific high-risk profile among the choices provided.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251219T234603131Z_kimi-k2-thinking_seed128", "question_id": "20251219T234603131Z_kimi-k2-thinking_seed128-020", "question": "A 35-year-old male in a personal injury lawsuit reports severe chronic pain despite normal examinations and imaging. He is observed to be inconsistent in his symptom presentation between evaluations. Which specific criterion best distinguishes malingering from factitious disorder in this scenario?", "options": ["Presence of secondary gain", "Intentional production of symptoms", "Lack of insight into psychological factors", "Symptoms are under voluntary control", "Absence of medical explanation"], "answer": "A", "answer_index": 0, "explanation": "Both malingering and factitious disorder involve intentional symptom production. The key distinction is motivation: malingering seeks external reward (money, avoiding work), while factitious disorder seeks the 'sick role' for psychological needs. Both have insight and voluntary control. Absence of medical explanation is common to both somatic symptom disorders.", "generator_model": "kimi-k2-thinking", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item correctly tests the fundamental distinction between malingering and factitious disorder. Both conditions involve the intentional production of symptoms (ruling out Option B) and are under voluntary control (ruling out Option D). The absence of a medical explanation (Option E) is common to both, as well as to somatic symptom disorders. The defining difference is the motivation: malingering is driven by external incentives (secondary gain), such as financial compensation, avoiding work, or obtaining drugs. In contrast, factitious disorder is motivated by an internal desire to assume the 'sick role' (primary gain) in the absence of obvious external rewards. The clinical vignette provides a classic setup for malingering (personal injury lawsuit), making the concept of secondary gain highly relevant. Option A is the unique best answer and aligns with standard DSM-5-TR criteria and board-exam teaching.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item correctly tests the fundamental distinction between malingering and factitious disorder. Both conditions involve the intentional production of symptoms (ruling out Option B) and are under voluntary control (ruling out Option D). The absence of a medical explanation (Option E) is common to both, as well as to somatic symptom disorders. The defining difference is the motivation: malingering is driven by external incentives (secondary gain), such as financial compensation, avoiding work, or obtaining drugs. In contrast, factitious disorder is motivated by an internal desire to assume the 'sick role' (primary gain) in the absence of obvious external rewards. The clinical vignette provides a classic setup for malingering (personal injury lawsuit), making the concept of secondary gain highly relevant. Option A is the unique best answer and aligns with standard DSM-5-TR criteria and board-exam teaching.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]